S&P 500   4,283.85
DOW   33,573.28
QQQ   354.84
High Dividend REITs: Are They an Ideal Way to Diversify?
The $193 Billion US-China War You Don't Know About (Ad)
Is Frontline's 20% Dividend Too Good To Be True?
Stock market today: World stocks mixed as Wall St inches toward bull market
Nevada Desert more Valuable than Wall Street or Silicon Valley? (Ad)
Here’s What’s Driving the Price of Carvana Higher
Tesla: How and Why It Gets To $300
Nevada Desert more Valuable than Wall Street or Silicon Valley? (Ad)
Wheat prices jump following collapse of major dam in southern Ukraine
Don't Overlook Hidden Gem Kinsale As Rallies To New Highs
S&P 500   4,283.85
DOW   33,573.28
QQQ   354.84
High Dividend REITs: Are They an Ideal Way to Diversify?
The $193 Billion US-China War You Don't Know About (Ad)
Is Frontline's 20% Dividend Too Good To Be True?
Stock market today: World stocks mixed as Wall St inches toward bull market
Nevada Desert more Valuable than Wall Street or Silicon Valley? (Ad)
Here’s What’s Driving the Price of Carvana Higher
Tesla: How and Why It Gets To $300
Nevada Desert more Valuable than Wall Street or Silicon Valley? (Ad)
Wheat prices jump following collapse of major dam in southern Ukraine
Don't Overlook Hidden Gem Kinsale As Rallies To New Highs
S&P 500   4,283.85
DOW   33,573.28
QQQ   354.84
High Dividend REITs: Are They an Ideal Way to Diversify?
The $193 Billion US-China War You Don't Know About (Ad)
Is Frontline's 20% Dividend Too Good To Be True?
Stock market today: World stocks mixed as Wall St inches toward bull market
Nevada Desert more Valuable than Wall Street or Silicon Valley? (Ad)
Here’s What’s Driving the Price of Carvana Higher
Tesla: How and Why It Gets To $300
Nevada Desert more Valuable than Wall Street or Silicon Valley? (Ad)
Wheat prices jump following collapse of major dam in southern Ukraine
Don't Overlook Hidden Gem Kinsale As Rallies To New Highs
S&P 500   4,283.85
DOW   33,573.28
QQQ   354.84
High Dividend REITs: Are They an Ideal Way to Diversify?
The $193 Billion US-China War You Don't Know About (Ad)
Is Frontline's 20% Dividend Too Good To Be True?
Stock market today: World stocks mixed as Wall St inches toward bull market
Nevada Desert more Valuable than Wall Street or Silicon Valley? (Ad)
Here’s What’s Driving the Price of Carvana Higher
Tesla: How and Why It Gets To $300
Nevada Desert more Valuable than Wall Street or Silicon Valley? (Ad)
Wheat prices jump following collapse of major dam in southern Ukraine
Don't Overlook Hidden Gem Kinsale As Rallies To New Highs
NYSE:ENFN

Enfusion (ENFN) Short Interest Ratio & Short Volume

$8.26
+0.20 (+2.48%)
(As of 06/6/2023 ET)
Compare
Today's Range
$8.05
$8.33
50-Day Range
$7.54
$10.50
52-Week Range
$7.37
$16.76
Volume
433,287 shs
Average Volume
524,314 shs
Market Capitalization
$960.56 million
P/E Ratio
206.55
Dividend Yield
N/A
Price Target
$11.08

Enfusion Short Interest Data

Current Short Volume
1,330,000 shares
Previous Short Volume
1,340,000 shares
Change Vs. Previous Month
-0.75%
Dollar Volume Sold Short
$10.48 million
Short Interest Ratio / Days to Cover
3.5
Last Record Date
May 15, 2023
Outstanding Shares
116,290,000 shares
Float Size
29,730,000 shares
Short Percent of Float
4.47%
Today's Trading Volume
433,287 shares
Average Trading Volume
524,314 shares
Today's Volume Vs. Average
83%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Enfusion ?

Sign up to receive the latest short interest report for Enfusion and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

ENFN Short Interest Over Time

ENFN Days to Cover Over Time

ENFN Percentage of Float Shorted Over Time


Enfusion (NYSE:ENFN) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
5/15/20231,330,000 shares $10.48 million -0.8%4.5%3.5 $7.88
4/30/20231,340,000 shares $11.23 million +0.8%5.0%3.6 $8.38
4/15/20231,330,000 shares $12.83 million +3.9%5.0%3.2 $9.65
3/31/20231,280,000 shares $13.44 million -9.2%4.4%3.2 $10.50
3/15/20231,410,000 shares $15.41 million -21.7%4.7%3.4 $10.93
2/28/20231,800,000 shares $19.30 million -0.6%7.1%4.4 $10.72
2/15/20231,810,000 shares $21.23 million -18.5%7.1%4.9 $11.73
1/31/20232,220,000 shares $26.37 million +19.4%8.5%5.6 $11.88
1/15/20231,860,000 shares $20.48 million -7.0%7.1%5.9 $11.01
12/30/20222,000,000 shares $19.34 million +20.5%7.6%6.4 $9.67
12/15/20221,660,000 shares $15.45 million -3.5%6.2%5.5 $9.31
11/30/20221,720,000 shares $16.43 million -6.5%6.7%5.9 $9.55
11/15/20221,840,000 shares $25.74 million -13.6%7.1%5.9 $13.99
10/31/20222,130,000 shares $30.18 million -14.8%8.0%6.8 $14.17
10/15/20222,500,000 shares $27.50 million +33.7%9.2%8.4 $11.00
9/30/20221,870,000 shares $23.08 million -7.9%6.7%6.6 $12.34
9/15/20222,030,000 shares $25.52 million +16.7%7.2%6.7 $12.57
8/31/20221,740,000 shares $21.56 million -3.3%6.4%5.3 $12.39
8/15/20221,800,000 shares $25.54 million -13.9%6.6%5.9 $14.19
7/31/20222,090,000 shares $24.04 million -7.5%8.0%6.7 $11.50
7/15/20222,260,000 shares $23.14 million -6.2%8.6%7 $10.24
6/30/20222,410,000 shares $24.61 million +8.6%9.2%7.1 $10.21
6/15/20222,220,000 shares $21.89 million +23.3%8.5%6.4 $9.86
5/31/20221,800,000 shares $19.71 million -3.7%6.9%6 $10.95
5/15/20221,870,000 shares $15.71 million -10.5%7.1%6 $8.40
4/30/20222,090,000 shares $26.69 million +7.7%7.5%7.8 $12.77
4/15/20221,940,000 shares $22.14 million -8.9%7.0%6.8 $11.41
3/31/20222,130,000 shares $27.09 million +24.6%6.3%7.9 $12.72
3/15/20221,710,000 shares $21.53 million -6.0%5.1%6.8 $12.59
2/28/20221,820,000 shares $30.19 million +51.7%N/A5.5 $16.59
2/15/20221,200,000 shares $20.23 million +50.4%N/A3.3 $16.86
1/31/2022797,800 shares $11.02 million -12.0%N/A2.4 $13.81
1/15/2022906,200 shares $15.06 million -21.9%21.3%2.3 $16.62
12/31/20211,160,000 shares $24.29 million No Change27.3%1.7 $20.94













ENFN Short Interest - Frequently Asked Questions

What is Enfusion's current short interest?

Short interest is the volume of Enfusion shares that have been sold short but have not yet been closed out or covered. As of May 15th, traders have sold 1,330,000 shares of ENFN short. 4.47% of Enfusion's shares are currently sold short. Learn More on Enfusion's current short interest.

What is a good short interest ratio for Enfusion?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ENFN shares currently have a short interest ratio of 4.0. Learn More on Enfusion's short interest ratio.

What is a good short interest percentage for Enfusion?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.47% of Enfusion's floating shares are currently sold short.

Is Enfusion's short interest increasing or decreasing?

Enfusion saw a decline in short interest during the month of May. As of May 15th, there was short interest totaling 1,330,000 shares, a decline of 0.7% from the previous total of 1,340,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Enfusion's float size?

Enfusion currently has issued a total of 116,290,000 shares. Some of Enfusion's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Enfusion currently has a public float of 29,730,000 shares.

How does Enfusion's short interest compare to its competitors?

4.47% of Enfusion's shares are currently sold short. Here is how the short interest of companies in the industry of "prepackaged software" compare to Enfusion: Couchbase, Inc. (3.57%), Avid Technology, Inc. (3.72%), Everbridge, Inc. (2.75%), VTEX (1.01%), WalkMe Ltd. (1.38%), Cerence Inc. (8.16%), Docebo Inc. (0.41%), Tuya Inc. (0.54%), Consensus Cloud Solutions, Inc. (2.95%), SecureWorks Corp. (2.46%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Enbridge Inc. ($4.29 billion), T-Mobile US, Inc. ($4.17 billion), Charter Communications, Inc. ($3.07 billion), Occidental Petroleum Co. ($2.81 billion), Moderna, Inc. ($2.37 billion), Coinbase Global, Inc. ($2.27 billion), T. Rowe Price Group, Inc. ($1.98 billion), Verisk Analytics, Inc. ($1.94 billion), Extra Space Storage Inc. ($1.88 billion), and Xylem Inc. ($1.61 billion). View all of the most shorted stocks.

What does it mean to sell short Enfusion stock?

Short selling ENFN is an investing strategy that aims to generate trading profit from Enfusion as its price is falling. ENFN shares are trading up $0.20 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Enfusion?

A short squeeze for Enfusion occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ENFN, which in turn drives the price of the stock up even further.

How often is Enfusion's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ENFN, twice per month. The most recent reporting period available is May, 15 2023.



More Short Interest Resources from MarketBeat

This page (NYSE:ENFN) was last updated on 6/7/2023 by MarketBeat.com Staff

My Account -